The Enduring Burden of Advanced Human Immunodeficiency Virus Disease

Overview

Journal Clin Infect Dis

Publisher Oxford University Press

Specialty Infectious Diseases

Date 2020 May 6

PMID 32369101

Citations 2

Authors

Nathan Ford

Eric Goemaere

Katherine Hildebrand

Carmen Perez-Casas

Affiliations

Soon will be listed here.

Citing Articles

Rapid antiretroviral therapy initiation in patients with advanced HIV disease: 6-month outcomes of an observational cohort evaluation in Lesotho.

Tiam A, Paulin H, Machekano R, Oboho I, Agyemang E, Mugyenyi F PLoS One. 2023; 18(10):e0292660.

PMID: 37819941 PMC: 10566720. DOI: 10.1371/journal.pone.0292660.

Advanced HIV disease and associated attrition after re-engagement in HIV care in Myanmar from 2003 to 2019: a retrospective cohort study.

Mesic A, Homan T, Lenglet A, Thit P, Mar H, Sabai S Int Health. 2022; 15(4):453-461.

PMID: 36318805 PMC: 10318975. DOI: 10.1093/inthealth/ihac069.

References

Ford N, Geng E, Ellman T, Orrell C, Ehrenkranz P, Sikazwe I . Emerging priorities for HIV service delivery. PLoS Med. 2020; 17(2):e1003028. PMC: 7021280. DOI: 10.1371/journal.pmed.1003028. View

Osler M, Hilderbrand K, Goemaere E, Ford N, Smith M, Meintjes G . The Continuing Burden of Advanced HIV Disease Over 10 Years of Increasing Antiretroviral Therapy Coverage in South Africa. Clin Infect Dis. 2018; 66(suppl_2):S118-S125. PMC: 5850025. DOI: 10.1093/cid/cix1140. View

Ford N, Meintjes G, Pozniak A, Bygrave H, Hill A, Peter T . The future role of CD4 cell count for monitoring antiretroviral therapy. Lancet Infect Dis. 2014; 15(2):241-7. DOI: 10.1016/S1473-3099(14)70896-5. View

Calmy A, Ford N, Meintjes G . The Persistent Challenge of Advanced HIV Disease and AIDS in the Era of Antiretroviral Therapy. Clin Infect Dis. 2018; 66(suppl_2):S103-SS105. PMC: 5850411. DOI: 10.1093/cid/cix1138. View

Panayidou K, Davies M, Anderegg N, Egger M . Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation. J Int AIDS Soc. 2019; 21(11):e25200. PMC: 6275813. DOI: 10.1002/jia2.25200. View

Mfinanga S, Chanda D, Kivuyo S, Guinness L, Bottomley C, Simms V . Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial. Lancet. 2015; 385(9983):2173-82. DOI: 10.1016/S0140-6736(15)60164-7. View

Munthali C, Taegtmeyer M, Garner P, Lalloo D, Squire S, Corbett E . Diagnostic accuracy of the WHO clinical staging system for defining eligibility for ART in sub-Saharan Africa: a systematic review and meta-analysis. J Int AIDS Soc. 2014; 17:18932. PMC: 4057784. DOI: 10.7448/IAS.17.1.18932. View

Avila D, Althoff K, Mugglin C, Wools-Kaloustian K, Koller M, Dabis F . Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries. J Acquir Immune Defic Syndr. 2014; 65(1):e8-16. PMC: 3894575. DOI: 10.1097/QAI.0b013e3182a39979. View

Hakim J, Musiime V, Szubert A, Mallewa J, Siika A, Agutu C . Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa. N Engl J Med. 2017; 377(3):233-245. PMC: 5603269. DOI: 10.1056/NEJMoa1615822. View

10.

Nasuuna E, Tenforde M, Muganzi A, Jarvis J, Manabe Y, Kigozi J . Reduction in Baseline CD4 Count Testing Following Human Immunodeficiency Virus "Treat All" Adoption in Uganda. Clin Infect Dis. 2020; 71(9):2497-2499. PMC: 7713677. DOI: 10.1093/cid/ciaa261. View

11.

Zanolini A, Sikombe K, Sikazwe I, Eshun-Wilson I, Somwe P, Moore C . Understanding preferences for HIV care and treatment in Zambia: Evidence from a discrete choice experiment among patients who have been lost to follow-up. PLoS Med. 2018; 15(8):e1002636. PMC: 6089406. DOI: 10.1371/journal.pmed.1002636. View

12.

Ford N, Meintjes G, Vitoria M, Greene G, Chiller T . The evolving role of CD4 cell counts in HIV care. Curr Opin HIV AIDS. 2017; 12(2):123-128. DOI: 10.1097/COH.0000000000000348. View